Navigation Links
Pandemic Influenza Global Clinical Trials Review, H1, 2016
Date:2/23/2016

NEW YORK, Feb. 23, 2016 /PRNewswire/ -- Pandemic Influenza Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Pandemic Influenza Global Clinical Trials Review, H1, 2016" provides an overview of Pandemic Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Pandemic Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Read the full report: http://www.reportlinker.com/p03638478-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Pandemic Influenza Global Clinical Trials Review, H2, 2015
2. Halyard Health Awarded Federal Contract to Research and Develop High-speed Machine to Produce Respirators for Use During Pandemics
3. Pandemic Influenza Therapeutic Pipeline Review H1 2015 Research Report
4. Prostate Cancer is Pandemic (World Wide) While the Rate of Failure is Epidemic!
5. NanoBio Awarded Up To $10 Million In NIH Funding To Develop A Pandemic Influenza Vaccine
6. Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015
7. Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015
8. "The 4th WHO Informal Consultation for Improving Influenza Vaccine Virus Selection" - A Global Meeting Co-organized by WHO and PolyU
9. CSL brands worlds no. 2 influenza vaccine provider as Seqirus
10. HSRx Group Completes Influenza Prevention Phase in Study of Novel Combination Drug for Flu Prevention & Treatment
11. NVS Influenza Vaccines Welcomes North Carolina Congresswoman Renee Ellmers on Tour of Holly Springs Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2019)... ... August 12, 2019 , ... Intalere, the healthcare industry leader in delivering optimal ... in the Innovator of The Year - Health IT category of the Pittsburgh Technology ... the Pittsburgh Technology Center as a healthcare IT innovator in the Pittsburgh area,” said ...
(Date:8/10/2019)... ... August 10, 2019 , ... Thumb sucking is natural for ... to 4 years of age, but past that the habit can contribute to dental ... to help parents know when to intervene and help their child stop the habit. ...
(Date:8/9/2019)... ... August 09, 2019 , ... Dr. Austin Cope ... a bachelor’s degree in biology from Dixie State University in St. George, Utah. He ... a doctor of medicine from Texas Tech University Health Sciences Center. He completed an ...
Breaking Medicine Technology:
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... revolutionize and standardize pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market ... set to launch its crowdfunding campaign to raise $50 million on September 9, ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri Arnaoutakis, a ... Haute Beauty Network. , The Haute Beauty Network, well known for its exclusive ... a hair restoration expert and our newest addition to the Haute Beauty members-only ...
(Date:8/15/2019)... , ... August 15, 2019 , ... ... , "The deadline for family planning clinics to provide written assurance that ... August 19. Similar to the Global Gag Rule, the new policy restricts ...
(Date:8/14/2019)... ... August 14, 2019 , ... ScribeAmerica, the ... has earned a place on the Inc. magazine 500/5000 list today for the ... a decade of ScribeAmerica’s recognition as one of the fastest growing companies in ...
(Date:8/14/2019)... Nev. (PRWEB) , ... August 13, 2019 , ... In ... and the purpose of doubt in your belief systems. , “Doubt can obliterate your ... start on the path to examining them to expand your understanding and your awareness. ...
Breaking Medicine News(10 mins):